| [1] |
Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) [J]. Eur Heart J, 2020，41(4)：543-603.
|
| [2] |
刘兴会，陈锰. 降低中国可避免的孕产妇死亡[J]. 中国实用妇科与产科杂志，2020，36(1)：54-56.
|
| [3] |
Royal College of Obstetricians and Gynaecologists.Reducing the risk of thrombosis and embolism during pregnancy and the puerperium [R/OL]．(2015-4)[2021-11-21]．
URL
|
| [4] |
American College of Obstetricians and Gynaecologists. ACOG Practice Bulletin No.196 Summary: Thromboembolism in Pregnancy [J]．Obstet Gynecol, 2018，132(1)：243-248.
|
| [5] |
Queensland Clinical Guidelines. VTE prophylaxis in pregnancy and the puerperium [R/OL]．(2020-03-01)[2021-11-21].
URL
|
| [6] |
上海市母婴安全专家委员会，上海市医学会围产医学专科分会，上海市医学会妇产科专科分会产科学组，等. 上海市产科静脉血栓栓塞症防治的专家共识 [J]．上海医学，2020，43(11): 640-650.
|
| [7] |
中华医学会妇产科学分会产科学组．妊娠期及产褥期静脉血栓栓塞症预防和诊治专家共识 [J]. 中华妇产科杂志，2021，56(4)：236-243.
|
| [8] |
王子莲，耿慧珍，赵先兰，等．中国九家医院孕产妇静脉血栓栓塞症发病现状及危险因素调查[J]．中华妇产科杂志，2020，55(10)：667-672.
|
| [9] |
崔宇童，李笑天，周琼洁．综合医院与专科医院孕产妇VTE防治现状的调查 [J]．中华妇产科杂志，2021，56(5)：310-316.
|
| [10] |
Waldman M, Sheiner E, Sergienko R，et al. Can we identify risk factors during pregnancy for thrombo-embolic events during the puerperium and later in life？[J]．J Matern Fetal Neonatal Med, 2015，28(9)：1005-1009.
|
| [11] |
Bai J, Ding X, Du X，et al. Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis [J]. Thromb Res, 2015，135(1)：90-95.
|
| [12] |
Huang W, Goldberg RJ, Anderson FA, et al. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009) [J]. Am J Med, 2014，127(9)：829-39.e5.
|
| [13] |
James AH.Venous thromboembolism in pregnancy[J]. Arterioscler Thromb Vasc Biol, 2009，29(3): 326-331.
|
| [14] |
National Health and Medical Research Council.Nutrient reference values [EB/OL]．(2020-1-16)[2021-11-21]．
URL
|
| [15] |
中国健康促进基金会血栓与血管专项基金专家委员会. 静脉血栓栓塞症机械预防中国专家共识[J]．中华医学杂志，2020，100(7): 484-492.
|
| [16] |
Jacobson B, Rambiritch V, Paek D, et al. Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis [J]. Adv Ther, 2020，37(1)：27-40.
|
| [17] |
Melbourne Australia. Therapeutic guidelines：therapies used for VTE prophylaxis [EB/OL](2019)[2021-11-21].
URL
|
| [18] |
MIMS Australia. MIMS Online：Heparin. [EB/OL]．(2018-7) [2021-11-21].
URL
|
| [19] |
Goel R, Patel EU, Cushing MM，et al. Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry [J]. JAMA Surg, 2018，153(9)：826-833.
|
| [20] |
Li HT, Luo S, Trasande L, et al. Geographic Variations and Temporal Trends in Cesarean Delivery Rates in China, 2008-2014 [J]. Jama, 2017，317(1)：69-76.
|
| [21] |
Blondon M, Casini A, Hoppe KK, et al. Risks of Venous Thromboembolism After Cesarean Sections: A Meta-Analysis [J]. Chest, 2016，150(3)：572-596.
|
| [22] |
王丹，阎萍．剖宫产术后的抗凝治疗[J/CD]．中华产科急救电子杂志，2019，8(4)：215-219.
|
| [23] |
Society for Maternal-Fetal Medicine (SMFM)．Society for Maternal-Fetal Medicine Consult Series #51: thromboembolism prophylaxis for cesarean delivery[J]. Am J Obstet Gynecol, 2021，224(2)：243-244.
|
| [24] |
Middleton P, Shepherd E, Gomersall JC.Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period [J]. Cochrane Database Syst Rev, 2021，3(3)：1-153.
|